ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.789,63
-0,31%
S&P 500
5.216,60
0,05%
US Dollar vs BRL
5,1593
0,33%
Bitcoin
60.310,90
-4,34%
Brent Oil
82,71
-1,48%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Penumbra Inc (PEN)

  7. Penumbra Inc (PEN) Notícias

PEN

Penumbra (PEN)

Penumbra Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:PEN
DataHoraFonteTítuloCódigoCompanhia
08/05/202420:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PENPenumbra Inc
07/05/202417:44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:PENPenumbra Inc
07/05/202417:14Edgar (US Regulatory)Form 8-K - Current reportNYSE:PENPenumbra Inc
07/05/202417:05PR Newswire (US)Penumbra, Inc. Reports First Quarter 2024 Financial ResultsNYSE:PENPenumbra Inc
01/05/202417:05PR Newswire (US)Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare ConferenceNYSE:PENPenumbra Inc
23/04/202410:00PR Newswire (US)Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood ClotsNYSE:PENPenumbra Inc
09/04/202417:05PR Newswire (US)Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024NYSE:PENPenumbra Inc
04/03/202420:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:PENPenumbra Inc
22/02/202418:46Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:PENPenumbra Inc
22/02/202418:05PR Newswire (US)Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsNYSE:PENPenumbra Inc
09/02/202419:46Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:PENPenumbra Inc
01/02/202418:05PR Newswire (US)Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024NYSE:PENPenumbra Inc
18/12/202321:50PR Newswire (US)Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare ConferenceNYSE:PENPenumbra Inc
28/11/202311:00PR Newswire (US)First Patient in STORM-PE RCT Enrolled Evaluating Penumbra's Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash™ - for Treatment of Acute Pulmonary EmbolismNYSE:PENPenumbra Inc
14/11/202318:05PR Newswire (US)Penumbra, Inc. to Present at the Piper Sandler 35th Annual Healthcare ConferenceNYSE:PENPenumbra Inc
10/11/202319:43PR Newswire (US)Penumbra Teams Up with Honor Everywhere to Bring US War Memorials to Aging VeteransNYSE:PENPenumbra Inc
02/11/202317:05PR Newswire (US)Penumbra, Inc. Reports Third Quarter 2023 Financial ResultsNYSE:PENPenumbra Inc
01/11/202317:05PR Newswire (US)NEW LATE BREAKING DATA DEMONSTRATE PENUMBRA'S COMPUTER ASSISTED VACUUM THROMBECTOMY TECHNOLOGY FOR PULMONARY EMBOLISM IMPROVED PATIENT OUTCOMESNYSE:PENPenumbra Inc
05/10/202317:05PR Newswire (US)Penumbra, Inc. Schedules Third Quarter 2023 Earnings Release and Conference Call for November 2, 2023NYSE:PENPenumbra Inc
23/08/202317:05PR Newswire (US)Penumbra, Inc. to Present at Upcoming Investor ConferencesNYSE:PENPenumbra Inc
03/08/202317:46Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NYSE:PENPenumbra Inc
01/08/202317:05PR Newswire (US)Penumbra, Inc. Reports Second Quarter 2023 Financial ResultsNYSE:PENPenumbra Inc
26/07/202317:05PR Newswire (US)Penumbra, Inc. to Present at the Canaccord Genuity 43rd Annual Growth ConferenceNYSE:PENPenumbra Inc
05/07/202317:05PR Newswire (US)Penumbra, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 1, 2023NYSE:PENPenumbra Inc
05/06/202320:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:PENPenumbra Inc
02/06/202318:04Edgar (US Regulatory)Current Report Filing (8-k)NYSE:PENPenumbra Inc
01/06/202310:00PR Newswire (US)Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated AspirationNYSE:PENPenumbra Inc
31/05/202317:07Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:PENPenumbra Inc
24/05/202317:05PR Newswire (US)Penumbra, Inc. to Present at William Blair's 43rd Annual Growth Stock ConferenceNYSE:PENPenumbra Inc
11/05/202317:26Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NYSE:PENPenumbra Inc
 Apresentando as notícias mais relevantes sobre:NYSE:PEN

Seu Histórico Recente

FX
USDCHF
US Dollar vs CHF
BOV
RVBI11
Vbr Reits Fof Fundo DE I...
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados